相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
Danielle Mandikian et al.
MOLECULAR CANCER THERAPEUTICS (2018)
CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape
David Pettitt et al.
MOLECULAR THERAPY (2018)
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics
Z. Wu et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies
Katherine E. Harris et al.
FRONTIERS IN IMMUNOLOGY (2018)
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding
Leah V. Sibener et al.
CELL (2018)
Regulatory mechanisms in T cell receptor signalling
Guillaume Gaud et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia (vol 29, pg 586, 2015)
A. M. Eiring et al.
LEUKEMIA (2017)
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
Haleh Saber et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Functionally Convergent B Cell Receptor Sequences in Transgenic Rats Expressing a Human B Cell Repertoire in Response to Tetanus Toxoid and Measles Antigens
Jean-Philippe Buerckert et al.
FRONTIERS IN IMMUNOLOGY (2017)
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment
Anja Seckinger et al.
CANCER CELL (2017)
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics
Carolyn C. Arpin et al.
MOLECULAR CANCER THERAPEUTICS (2016)
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects
Erin M. Scherer et al.
EBIOMEDICINE (2016)
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
David T. Teachey et al.
BLOOD (2013)
Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice
Geoffrey K. Isbister et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Human antibody expression in transgenic rats: Comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions
Biao Ma et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
T cell receptor signalling networks: branched, diversified and bounded
Rebecca J. Brownlie et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data What have we learned?
Rong Deng et al.
MABS (2011)
Intrachain disulfide bond in the core hinge region of human IgG4
James W. Bloom et al.
PROTEIN SCIENCE (2010)
Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases
Aron M. Geurts et al.
SCIENCE (2009)
Cooperativity Between T Cell Receptor Complexes Revealed by Conformational Mutants of CD3ε
Nuria Martinez-Martin et al.
SCIENCE SIGNALING (2009)
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
Ralf Bargou et al.
SCIENCE (2008)
Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice
Xiangang Zou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection:: a new source of viable human blood cells
Sonia Neron et al.
TRANSFUSION (2007)
T cell killing does not require the formation of a stable mature immunological synapse
MA Purbhoo et al.
NATURE IMMUNOLOGY (2004)
Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction:: Manifestation of a dual activation threshold
M Faroudi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The organizing principle in the formation of the T cell receptor-CD3 complex
ME Call et al.
CELL (2002)
In vitro characterization of five humanized OKT3 effector function variant antibodies
DL Xu et al.
CELLULAR IMMUNOLOGY (2000)